Agilitech Announces Chief Revenue Officer as Company Positions Itself For Further Growth
Agilitech appoints Phil Sanders to the role of Chief Revenue Officer, alongside his position as Biotech Chief Innovation Officer, as part of a strategic move towards achieving the company’s vision of growth.
Agilitech has appointed a CRO to reflect the evolution of the company over the last year, and to strategically support future growth across all industries and areas of operation. Phil Sanders joined the company in 2020, leading the launch of the pioneering Biotech group, and has been instrumental in shaping the Agilitech brand strategy and vision. In his role as CRO, Phil is committed to shaping the company’s future, developing and implementing the Business Development and overall Sales Strategy Plan, so that the company can confidently meet or exceed its financial goals moving forward.
As Agilitech looks toward the future, the company is focused on remaining true to its foundational values. This was a key consideration in appointing Sanders to the CRO position.
“We’re excited to have Phil on board as CRO. Phil has demonstrated an unwavering commitment to integrity and quality throughout his career, and his customer-centric approach to business aligns perfectly with Agilitech’s core values. We’re confident that Phil will play a pivotal role in guiding the company forward to continued growth and long-term success.”
– Alyssa Wolfer, Human Resources Manager
Phil brings an impressive wealth of knowledge and experience to Agilitech’s executive leadership team, including previous senior management positions in operations, sales and marketing, and finance, and the successful start up of two local automation companies. Throughout his career, he has demonstrated the ability to architect and implement success for an organization by recognizing opportunities for growth and developing the strategy to execute on that vision for significant revenue streams. His experience across different sectors, disciplines, and industries makes him well placed to successfully integrate a consistent and effective sales strategy across every operational group within Agilitech, resulting in sustainable revenue growth for the company as a whole.
Following the recent re-brand and launch into new industries, Agilitech is channeling this momentum into strategizing for growth. In his role as both Biotech Chief Innovation Officer and Agilitech CRO, Phil is set to be a dynamic and strategic force for the company’s mission of powering possibilities for today and tomorrow.
